Cannapharmarx, Inc. SEC filings CPMD
Cannapharmarx, Inc. has 365 filings in SEC EDGAR's recent list, going back to Jun 10, 1999. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 18, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jan 13, 2026 (officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 18, 2026 | Jun 30, 2026 |
| NT 10-Q | Filing | Aug 17, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 20, 2026 | Mar 31, 2026 |
| NT 10-Q | Filing | May 18, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Jan 13, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Other events
|
Dec 18, 2025 | Dec 12, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Other events
|
Oct 10, 2025 | Aug 7, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 16, 2025 | Mar 31, 2025 |
| NT 10-Q | Filing | May 16, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Other events
|
May 6, 2025 | May 6, 2025 |
| 10-K | Annual report | Apr 10, 2025 | Dec 31, 2024 |
| NT 10-K | Filing | Apr 1, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 31, 2025 | Mar 26, 2025 |
| 8-K |
Current report
Auditor change
|
Dec 3, 2024 | Nov 29, 2024 |
| 8-K |
Current report
Auditor change
|
Nov 21, 2024 | Nov 20, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 17, 2024 | Sep 9, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | Jun 25, 2024 | Mar 31, 2024 |
| 10-K | Annual report | May 16, 2024 | Dec 31, 2023 |
| NT 10-Q | 10-q extension | May 15, 2024 | Mar 31, 2024 |
| NT 10-K | Extension | Mar 27, 2024 | Dec 31, 2023 |
| 8-K/A | Amended current report | Feb 22, 2024 | Feb 15, 2024 |
| 8-K |
Current report
Material agreement
|
Feb 16, 2024 | Feb 15, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale
|
Dec 6, 2023 | Nov 22, 2023 |
| 10-Q | Quarterly report | Nov 17, 2023 | Sep 30, 2023 |
| NT 10-Q | Extension | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Auditor change
|
Nov 13, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 13, 2023 | Oct 9, 2023 |
| 10-Q | Quarterly report | Oct 13, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | Sep 22, 2023 | Mar 31, 2023 |
| 10-K | Annual report | Sep 1, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Officer or director change
|
Aug 28, 2023 | Mar 23, 2023 |
| 8-K |
Current report
Officer or director change
|
Jun 23, 2023 | Jun 1, 2023 |
| NT 10-K | Extension | Mar 30, 2023 | Dec 31, 2022 |
| 10-Q | Quarterly report | Nov 21, 2022 | Sep 30, 2022 |
| NT 10-Q | Request for extension | Nov 14, 2022 | Sep 30, 2022 |
| DEF 14A | Proxy statement | Oct 4, 2022 | Sep 28, 2022 |
| PRE 14A | Preliminary proxy statement | Aug 26, 2022 | Aug 25, 2022 |
| 10-Q | Quarterly report | Aug 22, 2022 | Jun 30, 2022 |
| NT 10-Q | Extension | Aug 12, 2022 | Jun 30, 2022 |
| EFFECT | Filing | Aug 11, 2022 | — |
| 424B3 | Prospectus | Aug 11, 2022 | — |
| S-1/A | Amended registration statement | Aug 9, 2022 | — |
| RW | Request for withdrawal | Aug 9, 2022 | — |
| CORRESP | Letter to the SEC | Aug 8, 2022 | — |
| S-1/A | Amended registration statement | Aug 8, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2022 | — |
| S-1 | Registration statement | Aug 1, 2022 | — |
| 10-Q | Quarterly report | May 23, 2022 | Mar 31, 2022 |
| NT 10-Q | Extension | May 16, 2022 | Mar 31, 2022 |
| 10-K | Annual report | Apr 15, 2022 | Dec 31, 2021 |
| NT 10-K | Filing | Mar 31, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 16, 2022 | Feb 14, 2022 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 16, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 16, 2021 | Jul 13, 2021 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 22, 2021 | Jun 22, 2021 |
| EFFECT | Filing | Jun 11, 2021 | — |
| 424B3 | Prospectus | Jun 10, 2021 | — |
| CORRESP | Letter to the SEC | Jun 9, 2021 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 9, 2021 | Jun 8, 2021 |
| CORRESP | Letter to the SEC | May 26, 2021 | — |
| S-1/A | Amended registration statement | May 26, 2021 | — |
| UPLOAD | Letter from the SEC | May 24, 2021 | — |
| 10-Q | Quarterly report | May 17, 2021 | Mar 31, 2021 |
| S-1 | Registration statement | May 14, 2021 | — |
| EFFECT | Filing | May 4, 2021 | — |
| POS AM | Filing | May 3, 2021 | — |
| CORRESP | Letter to the SEC | Apr 28, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 23, 2021 | — |
| POS AM | Pos am 2 | Apr 21, 2021 | — |
| CORRESP | Letter to the SEC | Apr 21, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 20, 2021 | — |
| POS AM | Post effective amendment no. 1 | Apr 15, 2021 | — |
| 10-K | Annual report | Apr 14, 2021 | Dec 31, 2020 |
| NT 10-K | 10-k extension | Apr 1, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 28, 2021 | Jan 28, 2021 |
| EFFECT | Filing | Jan 25, 2021 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 22, 2021 | Jan 22, 2021 |
| 424B3 | Prospectus | Jan 20, 2021 | — |
| CORRESP | Letter to the SEC | Jan 19, 2021 | — |
| S-1/A | Amended registration statement | Jan 15, 2021 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 12, 2021 | Jan 12, 2021 |
| CORRESP | Letter to the SEC | Dec 18, 2020 | — |
| S-1/A | Amended registration statement | Dec 18, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 15, 2020 | — |
| DEL AM | Delay request | Dec 2, 2020 | — |
| S-1 | Registration statement | Nov 27, 2020 | — |
| 10-Q | Quarterly report | Nov 12, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Aug 20, 2020 | Aug 20, 2020 |
| 10-Q | Quarterly report | Aug 19, 2020 | Jun 30, 2020 |
| NT 10-Q | Notice of late filing | Aug 14, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 6, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | Jun 29, 2020 | Mar 31, 2020 |
| DEF 14A | Proxy statement | Jun 29, 2020 | Jul 31, 2020 |
| 10-K/A | Amended annual report | Jun 22, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 10, 2020 | Jun 6, 2020 |
| 10-K | Annual report | May 27, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
May 20, 2020 | May 19, 2020 |
| 8-K |
Current report
Other events
|
May 14, 2020 | May 14, 2020 |
| NT 10-K | Extension for 10-k | May 14, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Other events
|
Mar 27, 2020 | Mar 26, 2020 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 17, 2020 | Mar 16, 2020 |
| 8-K |
Current report
Material agreement, New debt
|
Feb 10, 2020 | Jan 16, 2020 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 7, 2020 | Nov 27, 2019 |
| 10-K/A | Amended annual report | Dec 3, 2019 | Dec 31, 2018 |
| 10-Q/A | Amended quarterly report | Nov 20, 2019 | Jun 30, 2019 |
| 10-Q/A | Amended quarterly report | Nov 20, 2019 | Mar 31, 2019 |
| 10-Q | Quarterly report | Nov 14, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 3, 2019 | Oct 2, 2019 |
| 10-K/A | Amended annual report | Aug 14, 2019 | Dec 31, 2018 |
| 10-Q | Quarterly report | Aug 14, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Material agreement
|
Jun 12, 2019 | Jun 11, 2019 |
| 10-Q | Quarterly report | May 15, 2019 | Mar 31, 2019 |
| DEF 14A | Proxy statement | Apr 30, 2019 | Jun 21, 2019 |
| 8-K |
Current report
Officer or director change
|
Apr 26, 2019 | Apr 23, 2019 |
| 10-K | Annual report | Apr 3, 2019 | Dec 31, 2018 |
| NT 10-K | Notice of late filing | Apr 1, 2019 | Dec 31, 2018 |
| D | Filing | Mar 13, 2019 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Mar 1, 2019 | Feb 25, 2019 |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Feb 14, 2019 | Nov 19, 2018 |
| 8-K |
Current report
Unregistered share sale
|
Jan 30, 2019 | Jan 17, 2019 |
| D/A | Filing | Jan 18, 2019 | — |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jan 7, 2019 | Nov 19, 2018 |
| DEF 14C | Information statement | Dec 18, 2018 | Dec 18, 2018 |
| PRE 14C | Form pre14c | Dec 6, 2018 | Dec 5, 2018 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Nov 21, 2018 | Nov 19, 2018 |
| 10-Q | Quarterly report | Nov 13, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Sep 14, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | Sep 14, 2018 | Mar 31, 2018 |
| 10-K | Annual report | Sep 14, 2018 | Dec 31, 2017 |
| 10-Q | Quarterly report | Sep 14, 2018 | Sep 30, 2017 |
| 10-Q | Quarterly report | Sep 14, 2018 | Jun 30, 2017 |
| 10-Q | Quarterly report | Sep 14, 2018 | Mar 31, 2017 |
| 10-K | Annual report | Sep 14, 2018 | Dec 31, 2016 |
| 10-Q | Quarterly report | Sep 14, 2018 | Sep 30, 2016 |
| 10-Q | Quarterly report | Sep 14, 2018 | Jun 30, 2016 |
| 10-Q | Quarterly report | Sep 14, 2018 | Mar 31, 2016 |
| 10-K | Annual report | Sep 11, 2018 | Dec 31, 2015 |
| D | Filing | Aug 22, 2018 | — |
| 8-K |
Current report
Auditor change, Officer or director change
|
Jun 15, 2018 | Apr 20, 2018 |
| 8-K |
Current report
Other events
|
Apr 13, 2018 | Apr 12, 2018 |
| 8-K |
Current report
Officer or director change
|
Jun 2, 2016 | Jan 11, 2016 |
| 8-K |
Current report
Officer or director change
|
Apr 15, 2016 | Apr 6, 2016 |
| NT 10-K | Filing | Mar 30, 2016 | Dec 31, 2015 |
| 8-K |
Current report
Officer or director change
|
Jan 13, 2016 | Dec 18, 2015 |
| 10-Q | Quarterly report | Nov 13, 2015 | Sep 30, 2015 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Oct 6, 2015 | Oct 6, 2015 |
| 8-K |
Current report
Shareholder vote results
|
Aug 31, 2015 | Aug 28, 2015 |
| DEFA14A | Additional proxy material | Aug 24, 2015 | — |
| 10-Q | Quarterly report | Aug 12, 2015 | Jun 30, 2015 |
| D | Filing | Aug 10, 2015 | — |
| D/A | Filing | Aug 7, 2015 | — |
| DEF 14A | Proxy statement | Jul 17, 2015 | Aug 28, 2015 |
| 8-K |
Current report
Other events
|
Jul 7, 2015 | Jul 1, 2015 |
| 8-K |
Current report
Unregistered share sale, Change in control
|
Jul 2, 2015 | Jun 29, 2015 |
| 8-K/A |
Amended current report
Material agreement
|
May 28, 2015 | Mar 30, 2015 |
| 8-K |
Current report
Other events
|
May 27, 2015 | May 20, 2015 |
| 10-Q | Quarterly report | May 14, 2015 | Mar 31, 2015 |
| 8-K |
Current report
Unregistered share sale
|
Apr 29, 2015 | Apr 23, 2015 |
| D/A | Filing | Apr 29, 2015 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change in control
|
Apr 24, 2015 | Apr 21, 2015 |
| D | Filing | Apr 15, 2015 | — |
| 8-K |
Current report
Officer or director change
|
Apr 6, 2015 | Apr 1, 2015 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 3, 2015 | Mar 30, 2015 |
| 10-K | Annual report | Mar 31, 2015 | Dec 31, 2014 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 23, 2015 | Mar 23, 2015 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 3, 2015 | Feb 26, 2015 |
| 8-K |
Current report
Officer or director change
|
Feb 12, 2015 | Feb 9, 2015 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 17, 2014 | Dec 15, 2014 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 12, 2014 | Dec 1, 2014 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 9, 2014 | Dec 5, 2014 |
| DEF 14A | Proxy statement | Nov 21, 2014 | Nov 21, 2014 |
| 8-K |
Current report
Other events
|
Nov 21, 2014 | Nov 20, 2014 |
| 10-Q | Quarterly report | Nov 19, 2014 | Sep 30, 2014 |
| NT 10-Q | Filing | Nov 14, 2014 | Sep 30, 2014 |
| 8-K |
Current report
Officer or director change
|
Oct 27, 2014 | Oct 23, 2014 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 24, 2014 | Oct 23, 2014 |
| DEF 14A | Proxy statement | Oct 9, 2014 | Oct 8, 2014 |
| 8-K |
Current report
Officer or director change
|
Sep 29, 2014 | Sep 23, 2014 |
| PRE 14A | Preliminary proxy statement | Sep 26, 2014 | Sep 26, 2014 |
| 8-K |
Current report
Unregistered share sale, Officer or director change
|
Sep 19, 2014 | Sep 18, 2014 |
| 10-Q | Quarterly report | Sep 9, 2014 | Jun 30, 2014 |
| NT 10-Q | Filing | Aug 15, 2014 | Jun 30, 2014 |
| 8-K |
Current report
Unregistered share sale
|
Jun 20, 2014 | Jun 19, 2014 |
| D | Filing | Jun 4, 2014 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Jun 4, 2014 | May 15, 2014 |
| D | Filing | May 21, 2014 | — |
| 10-Q | Quarterly report | May 19, 2014 | Mar 31, 2014 |
| SC 14F1 | Filing | May 16, 2014 | — |
| 8-K |
Current report
Unregistered share sale, Change in control, Officer or director change, Other events
|
May 16, 2014 | May 9, 2014 |
| NT 10-Q | Filing | May 15, 2014 | Mar 31, 2014 |
| 10-K | Annual report | Feb 6, 2014 | Dec 31, 2013 |
| UPLOAD | Letter from the SEC | Feb 3, 2014 | — |
| 8-K/A |
Amended current report
Auditor change
|
Jan 31, 2014 | Jan 20, 2014 |
| CORRESP | Letter to the SEC | Jan 30, 2014 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CPMD (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Mountain View County
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1081938
- Former names
- GOLDEN DRAGON HOLDING CO. (until Oct 27, 2014); CCVG, INC. (until Jan 12, 2011); CONCORD VENTURES, INC. (until Nov 17, 2010); CAVION TECHNOLOGIES INC (until Jul 25, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.